EverSource Wealth Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.3K Buy
1,902
+461
+32% +$11K ﹤0.01% 2021
2025
Q4
$38.5K Buy
1,441
+258
+22% +$6.17K ﹤0.01% 1933
2025
Q3
$25.2K Buy
1,183
+215
+22% +$5.08K ﹤0.01% 2186
2025
Q2
$20.9K Sell
968
-717
-43% -$13.3K ﹤0.01% 2254
2025
Q1
$28K Buy
1,685
+815
+94% +$14.8K ﹤0.01% 1511
2024
Q4
$16K Buy
870
+571
+191% +$9.22K ﹤0.01% 1748
2024
Q3
$4.6K Sell
299
-59
-16% -$984 ﹤0.01% 2262
2024
Q2
$6.81K Buy
358
+238
+198% +$3.84K ﹤0.01% 2073
2024
Q1
$2.01K Buy
120
+98
+445% +$2.43K ﹤0.01% 2382
2023
Q4
$689 Buy
22
+1
+5% +$24 ﹤0.01% 2463
2023
Q3
$438 Hold
21
﹤0.01% 2403
2023
Q2
$503 Buy
+21
New +$467 ﹤0.01% 2354

Other funds holding ACAD